Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SynAct Pharma Major Shareholding Notification 2023

Oct 17, 2023

3114_iss_2023-10-17_d593e0d7-eab5-424a-a6f6-27f3765897c1.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Issuer SynAct Pharma AB

Holder

Colombus International Holdings, Inc.

Instrument

Instrument Shares SE0008241491
Before the transaction
Shares 0
Voting rights 0
Transaction
Date 11/10/2023
Limit for number of shares 10 %
Limit for number of votes 10 %

After the transaction

Quantity Shares 3,750,000 Directly held voting rights 0 Indirectly held voting rights 3,750,000

Percentage

Directly held shares 10.5423 % Directly held voting rights 0 % Indirectly held voting rights 10.5423 %

Resulting distribution of total

holdings
Percentage of voting
rights:
Number of underlying
shares:
Shares 10.5423 % 3,750,000
paragraph, line 2 Instruments - FITA Ch. 4, section 2, first
first paragraph, line 3 Instruments - FITA Ch. 4, section 2,
- Physically settled
- Cash settled
Total 10.5423 % 3,750,000
Chain
of
controlling
companies
Voting rights % Voting rights Company
0 0 Colombus International Holdings, Inc
0 0 CVI Holdings, LLC
3,750,000 10.5423 CVI Investments, Inc
total
holdings
Group
Voting rights 3,750,000

Percentage of voting rights 10.5423

Published

17/10/2023 09:23

Contact

Name Timothy Sjövall

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25